The catalytic function of NQO1 in the reduction of quinones to hydroquinones is required for the activation of quinone-containing alkylating agents such as mitomycins, an important group of compounds used in the treatment of lung cancer for decades [12]. The gene discussed is NQO1; the disease is lung cancer.